Literature DB >> 2181313

Biology and management of bladder cancer.

D Raghavan1, W U Shipley, M B Garnick, P J Russell, J P Richie.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2181313     DOI： 10.1056/NEJM199004193221607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  70 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

2.  Contributions of incidence and case fatality to mortality from bladder cancer in the south Thames Regions.

Authors:  A Walker; A Petruckevitch; H Bourne; P Burney
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

3.  The consequence of delayed fixation on subsequent preservation of urine cells.

Authors:  Hussain G Ahmed; Murtada Am Tom
Journal:  Oman Med J       Date:  2011-01

4.  ACP Broadsheet 130: November 1991. Gross examination of bladder specimens.

Authors:  M C Parkinson; C Fisher
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

5.  CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors.

Authors:  N E Stavropoulos; I Filliadis; E Ioachim; M Michael; E Mermiga; K Hastazeris; U O Nseyo
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Isolation and characterization of a novel bladder cancer cell line: inhibition by epidermal growth factor.

Authors:  H Pratsinis; A Saetta; S Gagos; P Davaris
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

7.  Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling.

Authors:  Yigang Qian; Junfang Deng; Haiyang Xie; Lei Geng; Lin Zhou; Yan Wang; Shenyong Yin; Xiaowen Feng; Shusen Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-30       Impact factor: 4.553

8.  Interferon beta enhances the natural killer activity of patients with bladder carcinoma.

Authors:  L Moltó; J Carballido; L Manzano; C Olivier; P Lapeña; M Alvarez-Mon
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

9.  The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.

Authors:  Kyung Won Kwak; Sun Hee Kim; Hyun Moo Lee
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

10.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.